Xi Jinping and Vladimir Putin, both 72, recently sparked global intrigue by discussing life extension during a Forbidden City stroll, according to a viral video. Their conversation touched on replacing organs to combat aging, echoing a broader trend among elites. Peter Thiel, Sam Altman, and Jeff Bezos are funneling hundreds of millions into biotech ventures like Retro Biosciences ($180 million) and Altos Labs, betting on stem cell therapies to delay death. Bryan Johnson's Project Blueprint epitomizes this obsession, blending supplements, gene therapy, and plasma transfusions from his son to chase biological youth. These efforts, though scientifically contested, reveal a cultural shift: the wealthy are no longer content with power—they seek to defy mortality itself.

The pursuit raises ethical questions about inequality and the concentration of life-extending technologies in the hands of the few.